Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Waitz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Radiology|April 1, 2009
Can local radiofrequency ablation of tumors generate systemic immunity against metastatic disease?Rebecca Waitz, Stephen B Solomon
Oncoimmunology|July 4, 2012
CTLA-4 blockade synergizes with cryoablation to mediate tumor rejectionRebecca Waitz, Marcella Fassò, James P Allison
Frontiers in Immunology|May 14, 2021
Protein-Based Immunome Wide Association Studies (PIWAS) for the Discovery of Significant Disease-Associated AntigensWinston A Haynes, Kathy Kamath, Rebecca Waitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2003
B7x: a widely expressed B7 family member that inhibits T cell activationXingxing Zang, P'ng Loke, Jayon Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2005
Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infectionP'ng Loke, Xingxing Zang, Lisa Hsuan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2008
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockadeMarcella Fassò, Rebecca Waitz, Yafei Hou, et al.
Cancer Research|November 24, 2011
Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapyRebecca Waitz, Stephen B Solomon, Elena N Petre, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2012
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor modelPing Yu, Jason C Steel, Meili Zhang, et al.
Cancer Immunology Research|July 1, 2015
Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate CancerKatharina Kreymborg, Stefan Haak, Rajmohan Murali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in miceMeili Zhang, Wei Ju, Zhengsheng Yao, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Radiology|April 1, 2009
Can local radiofrequency ablation of tumors generate systemic immunity against metastatic disease?Rebecca Waitz, Stephen B Solomon
Oncoimmunology|July 4, 2012
CTLA-4 blockade synergizes with cryoablation to mediate tumor rejectionRebecca Waitz, Marcella Fassò, James P Allison
Frontiers in Immunology|May 14, 2021
Protein-Based Immunome Wide Association Studies (PIWAS) for the Discovery of Significant Disease-Associated AntigensWinston A Haynes, Kathy Kamath, Rebecca Waitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2003
B7x: a widely expressed B7 family member that inhibits T cell activationXingxing Zang, P'ng Loke, Jayon Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2005
Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infectionP'ng Loke, Xingxing Zang, Lisa Hsuan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2008
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockadeMarcella Fassò, Rebecca Waitz, Yafei Hou, et al.
Cancer Research|November 24, 2011
Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapyRebecca Waitz, Stephen B Solomon, Elena N Petre, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2012
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor modelPing Yu, Jason C Steel, Meili Zhang, et al.
Cancer Immunology Research|July 1, 2015
Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate CancerKatharina Kreymborg, Stefan Haak, Rajmohan Murali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in miceMeili Zhang, Wei Ju, Zhengsheng Yao, et al.
Pageof 2